BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 28110056)

  • 1. Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies.
    Picard M; Galvão VR
    J Allergy Clin Immunol Pract; 2017; 5(3):600-609. PubMed ID: 28110056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal Antibodies Hypersensitivity: Prevalence and Management.
    Santos RB; Galvão VR
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):695-711. PubMed ID: 28965635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
    Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
    J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.
    Picard M; Castells MC
    Clin Rev Allergy Immunol; 2015 Oct; 49(2):177-91. PubMed ID: 24740483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes.
    Isabwe GAC; Garcia Neuer M; de Las Vecillas Sanchez L; Lynch DM; Marquis K; Castells M
    J Allergy Clin Immunol; 2018 Jul; 142(1):159-170.e2. PubMed ID: 29518427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of adverse reactions to biologic agents.
    Isabwe GAC; de Las Vecillas Sanchez L; Castells M
    Allergy Asthma Proc; 2017 Nov; 38(6):409-418. PubMed ID: 29046192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.
    Picard M; Pur L; Caiado J; Giavina-Bianchi P; Galvão VR; Berlin ST; Campos SM; Matulonis UA; Castells MC
    J Allergy Clin Immunol; 2016 Apr; 137(4):1154-1164.e12. PubMed ID: 26725998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity Reactions to Monoclonal Antibodies in Children.
    Mori F; Saretta F; Bianchi A; Crisafulli G; Caimmi S; Liotti L; Bottau P; Franceschini F; Paglialunga C; Ricci G; Santoro A; Caffarelli C
    Medicina (Kaunas); 2020 May; 56(5):. PubMed ID: 32408641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization for hypersensitivity reactions to medications.
    del Carmen Sancho M; Breslow R; Sloane D; Castells M
    Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Hypersensitivity and Desensitizations: Mechanisms and New Approaches.
    de Las Vecillas Sánchez L; Alenazy LA; Garcia-Neuer M; Castells MC
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Hypersensitivity Reactions to Taxanes.
    Picard M
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):679-693. PubMed ID: 28965634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization.
    Castells M; Sancho-Serra Mdel C; Simarro M
    Cancer Immunol Immunother; 2012 Sep; 61(9):1575-84. PubMed ID: 22576054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of drug hypersensitivity reactions.
    Romano A; Torres MJ; Castells M; Sanz ML; Blanca M
    J Allergy Clin Immunol; 2011 Mar; 127(3 Suppl):S67-73. PubMed ID: 21354502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century.
    Castells Guitart MC
    J Investig Allergol Clin Immunol; 2014; 24(2):72-9; quiz 2 p following 79. PubMed ID: 24834769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Children with Hypersensitivity to Antibiotics and Monoclonal Antibodies.
    Norton AE; Broyles AD
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):713-725. PubMed ID: 28965636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Testing in the Evaluation and Management of Carboplatin-Related Hypersensitivity Reactions.
    Lax T; Long A; Banerji A
    J Allergy Clin Immunol Pract; 2015; 3(6):856-62. PubMed ID: 26432514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Road Less Traveled: Drug Hypersensitivity to Fluoroquinolones, Vancomycin, Tetracyclines, and Macrolides.
    Zhu LJ; Liu AY; Wong PH; Arroyo AC
    Clin Rev Allergy Immunol; 2022 Jun; 62(3):505-518. PubMed ID: 35092578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
    Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
    Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing and managing patients with drug hypersensitivity.
    Fernandez J; Doña I
    Expert Rev Clin Immunol; 2018 Jan; 14(1):29-41. PubMed ID: 29202594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity Reactions to Platinum Agents and Taxanes.
    Tsao LR; Young FD; Otani IM; Castells MC
    Clin Rev Allergy Immunol; 2022 Jun; 62(3):432-448. PubMed ID: 34338975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.